logo
Emissions standard debate: Centre defends SO₂ norms tweak, justifies rationale citing IIT, NEERI studies

Emissions standard debate: Centre defends SO₂ norms tweak, justifies rationale citing IIT, NEERI studies

Time of India5 days ago
The central government on Monday defended its controversial move to ease sulphur dioxide (SO₂) emission norms for thermal power plants, asserting that the revised rules were based on detailed scientific analysis and extensive consultations.
It also criticised media reports calling the move a 'regulatory dilution', saying they had 'grossly misinterpreted' the policy's intent and rationale.
The clarification comes in response to mounting criticism following the environment ministry's July 11 notification, which extended emission deadlines and exempted hundreds of coal-fired plants—classified as Category C—from installing flue gas desulphurisation (FGD) units.
In a statement issued Monday, the ministry said: 'Media reports misrepresent both the scientific evidence and the environmental policy rationale underlying the revised notification.' It emphasised that the decision followed consultations with stakeholders and premier research institutions, including IIT Delhi, the National Institute of Advanced Studies (NIAS), the National Environmental Engineering Research Institute (NEERI), and the Central Pollution Control Board (CPCB).
'Contrary to claims of regulatory dilution, the ministry's decision represents a rational, evidence-based recalibration anchored in current ambient air quality data, sectoral emission trends and broader sustainability imperatives,' the statement said, PTI reported.
The ministry pushed back against suggestions that India's National Ambient Air Quality Standards (NAAQS) for SO₂—last revised in 2009—are outdated, calling such claims 'scientifically unfounded.'
It said any revision to SO₂ limits must be based on actual contributions to PM2.5 levels and associated health impacts, rather than 'rhetorical assertions.' The ministry cited a study by IIT Delhi, which showed that sulfate—formed from SO₂—contributed only 0.96% to 5.21% of PM2.5, and 0.57% to 3.67% of PM10, in cities near thermal power plants.
By contrast, the ministry said, claims that sulphur compounds contribute 12–30% to PM2.5 were 'unsubstantiated' and not backed by any rigorous Indian study.
'Current exposure levels provide no credible evidence to suggest that SO₂, under prevailing ambient conditions, is a major public health concern,' it said.
The revised notification retains the December 2027 compliance deadline for Category A plants—those located within a 10-km radius of the National Capital Region or cities with a population of over 1 million.
For Category B plants—those near critically polluted areas or non-attainment cities—the ministry has moved from a fixed 2025 deadline to a case-by-case assessment approach.
The most sweeping change applies to Category C plants, which comprise the bulk of India's thermal fleet. These units have been completely exempted from installing FGD units, provided they comply with prescribed stack height norms by December 31, 2029. The earlier deadline was December 2026.
Of roughly 600 thermal power units in India, 462 are in Category C and 72 in Category B, according to the ministry.
India first announced SO₂ emission standards for coal-based power plants in December 2015, mandating FGD installation within two years.
But nearly a decade and four extensions later, 92% of plants are yet to comply.
Environmental groups have expressed concern that this rollback will worsen India's already severe air pollution crisis. Medical experts have long linked SO₂ exposure and secondary PM2.5 formation to respiratory and cardiovascular ailments.
However, the government insisted that its revised standards strike a balance between environmental objectives and energy sector realities. 'This is not a dilution, but a strategic recalibration based on evolving scientific and sectoral evidence,' the ministry said.
Stay informed with the latest
business
news, updates on
bank holidays
and
public holidays
.
AI Masterclass for Students. Upskill Young Ones Today!– Join Now
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Samosa, Jalebi Under Scrutiny: Govt Flags Popular Snacks for Health Risks, Suggests Healthier Alternatives
Samosa, Jalebi Under Scrutiny: Govt Flags Popular Snacks for Health Risks, Suggests Healthier Alternatives

Hans India

time27 minutes ago

  • Hans India

Samosa, Jalebi Under Scrutiny: Govt Flags Popular Snacks for Health Risks, Suggests Healthier Alternatives

India's favourite street-side treats—samosas and jalebis—are facing increasing criticism over their impact on public health. Recognising the alarming rise in lifestyle-related ailments, the Indian government has rolled out a pioneering campaign in Nagpur to raise awareness about the dangers of these beloved yet unhealthy snacks. In a move akin to cigarette warning labels, authorities are now placing prominent health warnings on high-fat, high-sugar items such as samosas, jalebis, pakoras, vada pav, and even chai biscuits. The initiative, launched at All India Institute of Medical Sciences (AIIMS) Nagpur, hopes to nudge citizens toward mindful eating by spotlighting the excessive oil, sugar, and trans fats present in these snacks. Why You Should Think Twice Before Reaching for That Samosa or Jalebi These popular items might be tasty, but experts warn that they come with a hefty price tag for your health: Calorie Bombs: Deep-fried and sugar-syrup-soaked, these treats pack in more calories than you might think. Regular consumption may contribute to unwanted weight gain. Deep-fried and sugar-syrup-soaked, these treats pack in more calories than you might think. Regular consumption may contribute to unwanted weight gain. Raises Bad Cholesterol: The trans fats used in frying can spike LDL (bad cholesterol) while lowering HDL (good cholesterol), increasing your risk of heart issues. The trans fats used in frying can spike LDL (bad cholesterol) while lowering HDL (good cholesterol), increasing your risk of heart issues. Obesity Risk: Consistent indulgence in calorie-dense foods contributes directly to obesity—a root cause of numerous chronic conditions. Consistent indulgence in calorie-dense foods contributes directly to obesity—a root cause of numerous chronic conditions. Blood Sugar Spikes: Jalebis are sugar-heavy, while samosas often use refined flour—both of which can increase blood sugar levels and insulin resistance over time. Healthy Craving Busters: 5 Low-Calorie Indian Snack Options Instead of reaching for deep-fried or sugar-drenched snacks, nutritionists recommend these wholesome alternatives that offer flavour without compromising your health: Roasted Chana: Crunchy and protein-rich, roasted chana makes a satisfying snack. Add a pinch of masala for a delicious, guilt-free boost. Vegetable Upma: Light and full of fibre, this wholesome dish combines vegetables with semolina to keep you full and energised through the day. Masala Oats: Oats get a spicy desi upgrade with herbs and masala—making them a hearty, fibre-rich snack that satisfies your taste buds. Moong Dal Chilla: Made with ground moong dal and spices, this protein-packed pancake is both nutritious and filling—perfect for any time of day. Makhana Bhel: Swap fried bhel for this light version made with roasted fox nuts, vegetables, and tangy spices—a great way to stay on track. As the push for food labelling and consumer awareness gains momentum, it's time to rethink our plate and embrace smarter snack choices. Small swaps today can protect against big health issues tomorrow.

'Exploited patients for sex': Indian-origin doctor in New Jersey charged with medical fraud, assault on female patients
'Exploited patients for sex': Indian-origin doctor in New Jersey charged with medical fraud, assault on female patients

Time of India

time44 minutes ago

  • Time of India

'Exploited patients for sex': Indian-origin doctor in New Jersey charged with medical fraud, assault on female patients

Indian-origin doctor charged in New Jersey for prescribing opioids taking sexual favors from patients. Ritesh Kalra, an Indian-origin New Jersey doctor, has been charged with multiple medical frauds, including the distribution of opioids without any legitimate medical purpose, billing the visits that never happened. Kalra also solicited sexual favors from patients in exchange for opioid prescriptions. According to DOJ documents, Kalwa is now on home arrest and is also prohibited from practicing medicine and prescribing medication and will be required to shut down his medical practice while the case is pending. Opioid prescriptions without medical purpose Dr Kalra allegedly operated a pill mill out of his medical office, where he routinely prescribed high-dose opioids—including oxycodone—and promethazine with codeine to patients without a legitimate medical purpose. Between January 2019 and February 2025, Kalra issued more than 31,000 prescriptions for oxycodone, including days when he wrote upwards of 50 prescriptions. Sexual favors for opioid prescription Several of Kalra's former employees claimed that female patients complained that Kalra touched them sexually and demanded sexual favors of them, including oral sex, in order to obtain their prescriptions. One patient even claimed she was forced to do anal sex during her clinical appointments. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like They Were So Beautiful Before; Now Look At Them; Number 10 Will Shock You Reportingly Undo Another patient continued to receive opioid prescriptions from Kalra when the patient was incarcerated at Essex County Correctional Facility and had no contact with Kalra. False bills for in-person visits that never happened Kalra also allegedly billed for in-person visits and counseling sessions that never occurred. As part of the health care fraud scheme, Kalra's electronic medical records allegedly contained false progress notes listing fabricated dates of service, and included examination notes that were generally identical from visit to visit and did not record vital signs. US attorney Alina Habba said Dr Kalsa used the position of responsibility held by physicians to fuel addiction among his patients. 'Physicians hold a position of profound responsibility—but as alleged, Dr. Kalra used that position to fuel addiction, exploit vulnerable patients for sex, and defraud New Jersey's public healthcare program. By allegedly exchanging prescriptions for sexual favors and billing Medicaid for ghost appointments, he not only violated the law but endangered lives. Our Office will continue to pursue those who turn their medical licenses into tools for personal gain and sexual gratification," Alina Habba said.

Multilingual trailer for ‘TRON: Ares' dropped; date locked for Indian release
Multilingual trailer for ‘TRON: Ares' dropped; date locked for Indian release

Hans India

timean hour ago

  • Hans India

Multilingual trailer for ‘TRON: Ares' dropped; date locked for Indian release

Disney has unveiled the much-awaited language trailer of TRON: Ares, the third chapter in its iconic TRON franchise. The film, a sequel to the groundbreaking 1982 sci-fi classic TRON and its visually stunning 2010 follow-up TRON: Legacy, is all set to release in Indian theatres on October 10, 2025, in English, Hindi, Tamil, and Telugu. Directed by Joachim Rønning, TRON: Ares takes the franchise into bold new territory. The story follows Ares, a highly advanced Program, who is transported from the digital Grid into the real world for a perilous mission. This journey marks humanity's first direct contact with artificial intelligence entities—ushering in high-stakes action and philosophical dilemmas that are signature to the TRON universe. The new trailer has created quite a buzz, especially with the inclusion of an electrifying new track by Grammy-winning band Nine Inch Nails, titled "As Alive As You Need Me To Be". The haunting score adds to the film's futuristic, edgy tone, giving fans a taste of the immersive world they're about to enter. The star-studded ensemble is led by Jared Leto as Ares, with Greta Lee, Evan Peters, Hasan Minhaj, Jodie Turner-Smith, Arturo Castro, Cameron Monaghan, Gillian Anderson, and legendary TRON actor Jeff Bridges also on board. Produced by Sean Bailey, Jeffrey Silver, Justin Springer, Jared Leto, Emma Ludbrook, and original TRON creator Steven Lisberger, with Russell Allen as executive producer, TRON: Ares is being positioned as both a visual spectacle and a timely exploration of A.I. and digital consciousness. With its multilingual release, Disney aims to take the legacy of TRON deeper into the Indian market, ensuring fans across languages can experience the digital revolution on the big screen.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store